Osvaldo Flores - Feb 2, 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Executive Officer
Signature
/s/ Michael Diem, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/6/2023, 05:52 PM
Previous filing
Jan 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +638K $0.00 638K Feb 2, 2023 Common Stock 638K $4.64 Direct F1
transaction IPSC Stock Option (right to buy) Award $0 +638K $0.00 638K Feb 2, 2023 Common Stock 638K $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.